title: Encapsulation and Controlled Release of Heparin from Electrospun Poly(L-Lactide-co-ε-Caprolactone) Nanofibers.
abstract: Poly(L-lactide-co-ε-caprolactone) nanofibers with heparin incorporated were successfully fabricated by coaxial electrospinning. The morphologies of electrospun nanofibers were studied by scanning electron microscopy (SEM), and a significant decrease in fiber diameter was observed with increasing heparin concentration. The transmission electron microscopy (TEM) images indicated that coaxial electrospinning could generate core-shell structure nanofibers which have the potential to encapsulate drugs (heparin in this study) into the core part of nanofibers. Approximately 80% of the encapsulated heparin was sustainedly and stably released from the fibrous composite in 14 days by a diffusion/erosion coupled mechanism. The release behavior of heparin from blend electrospun nanofibers was also studied and showed an obvious burst release in the initial stage. An in vitro proliferation test was conducted to study the effect of heparin released from nanofibers, and the results suggest that the heparin maintains its bioactivity after encapsulating with and delivery through coaxially electrospun fibers.
authors.affiliation: a State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Donghua University, Shanghai 201620, P. R. China; Key Laboratory of Textile Science & Technology, Ministry of Education, Donghua University, Shanghai 201620, P. R. China; Biomaterials and Tissue Engineering Laboratory, College of Chemistry & Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, P. R. China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Su
authors.forename: Xiaoqiang
authors.initials: X
authors.lastname: Li
authors.forename: Yinan
authors.initials: Y
authors.lastname: Liu
authors.forename: Qianqian
authors.initials: Q
authors.lastname: Su
authors.forename: Marcus Lim Wei
authors.initials: ML
authors.lastname: Qiang
authors.forename: Xiumei
authors.initials: X
authors.lastname: Mo
mesh_terms: D002478:Cells, Cultured; D003692:Delayed-Action Preparations / Q000737:chemistry; D004058:Diffusion; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006493:Heparin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000502:physiology; D057139:Nanofibers / Q000737:chemistry / Q000648:ultrastructure; D011091:Polyesters / Q000737:chemistry; D013718:Tensile Strength
chemical_list: D003692:Delayed-Action Preparations; D005343:Fibrinolytic Agents; D011091:Polyesters; C062968:lactide-caprolactone copolymer; D006493:Heparin